CD274 and neoplasm: Overall, MDSCs boost immunosuppression by blocking the migration of CD 8+ T cells to the tumor, downregulating T cell receptors, decreasing reactive oxygen species (ROS), increasing the hypoxia-inducible factor, and upregulating PD-L1 [21].